{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:34:22Z","timestamp":1789731262075,"version":"4.0.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T00:00:00Z","timestamp":1469059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["NMRC\/CG\/016\/2013"],"award-info":[{"award-number":["NMRC\/CG\/016\/2013"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001469","name":"Singapore General Hospital","doi-asserted-by":"publisher","award":["SRG #09\/2011"],"award-info":[{"award-number":["SRG #09\/2011"]}],"id":[{"id":"10.13039\/501100001469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["EDG11may068"],"award-info":[{"award-number":["EDG11may068"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0158740","type":"journal-article","created":{"date-parts":[[2016,7,21]],"date-time":"2016-07-21T17:41:56Z","timestamp":1469122916000},"page":"e0158740","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["From Bench-Top to Bedside: A Prospective In Vitro Antibiotic Combination Testing (iACT) Service to Guide the Selection of Rationally Optimized Antimicrobial Combinations against Extensively Drug Resistant (XDR) Gram Negative Bacteria (GNB)"],"prefix":"10.1371","volume":"11","author":[{"given":"Yiying","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie Grace","family":"Chua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Peng","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn Qi-Min","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winnie","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asok","family":"Kurup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tse-Hsien","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuan-Tong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea L.","family":"Kwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,21]]},"reference":[{"issue":"1","key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America","volume":"48","author":"HW Boucher","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.47102\/annals-acadmedsg.V41N5p189","article-title":"The excess financial burden of multidrug resistance in severe gram-negative infections in Singaporean hospitals","volume":"41","author":"E Ng","year":"2012","journal-title":"Ann Acad Med Singapore"},{"issue":"6","key":"ref3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.ajic.2014.01.027","article-title":"Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units","volume":"42","author":"SJ Patel","year":"2014","journal-title":"American journal of infection control"},{"issue":"6","key":"ref4","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1093\/jac\/dkm357","article-title":"Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review","volume":"60","author":"AP Zavascki","year":"2007","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 2","key":"ref5","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1093\/cid\/cir475","article-title":"Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections\u2014proceedings and data from the Gram-Negative Resistance Summit","volume":"53","author":"MH Kollef","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"5","key":"ref6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0972-5229.132495","article-title":"Current concepts in combination antibiotic therapy for critically ill patients","volume":"18","author":"A Ahmed","year":"2014","journal-title":"Indian journal of critical care medicine: peer-reviewed, official publication of Indian Society of Critical Care Medicine"},{"issue":"12","key":"ref7","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1586\/14787210.2013.845523","article-title":"Combination therapy for carbapenem-resistant Gram-negative bacteria","volume":"11","author":"AP Zavascki","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"10","key":"ref8","doi-asserted-by":"crossref","first-page":"4201","DOI":"10.1128\/AAC.00008-10","article-title":"Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae","volume":"54","author":"B Kitchel","year":"2010","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"4","key":"ref9","doi-asserted-by":"crossref","first-page":"e18485","DOI":"10.1371\/journal.pone.0018485","article-title":"In-vitro activity of polymyxin B, rifampicin, tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii in Singapore","volume":"6","author":"TP Lim","year":"2011","journal-title":"PloS one"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ijantimicag.2011.01.005","article-title":"A set of multiplex PCRs for genotypic detection of extended-spectrum beta-lactamases, carbapenemases, plasmid-mediated AmpC beta-lactamases and OXA beta-lactamases","volume":"37","author":"GM Voets","year":"2011","journal-title":"International journal of antimicrobial agents"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5365\/wpsar.2011.2.4.010","article-title":"Molecular characterization of NDM-1 producing Enterobacteriaceae isolates in Singapore hospitals","volume":"3","author":"J Teo","year":"2012","journal-title":"Western Pacific surveillance and response journal: WPSAR"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/jac\/dks535","article-title":"Tigecycline susceptibility in Klebsiella pneumoniae and Escherichia coli causing neonatal septicaemia (2007\u201310) and role of an efflux pump in tigecycline non-susceptibility","volume":"68","author":"S Roy","year":"2013","journal-title":"The Journal of antimicrobial chemotherapy"},{"issue":"Pt 1","key":"ref13","article-title":"Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia","volume":"161","author":"SD Aaron","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/AAC.42.4.849","article-title":"Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults","volume":"42","author":"M Tod","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1592\/phco.22.15.1216.33484","article-title":"Pharmacokinetics of intravenous and oral levofloxacin in critically ill adults in a medical intensive care unit","volume":"22","author":"JA Rebuck","year":"2002","journal-title":"Pharmacotherapy"},{"issue":"5","key":"ref16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijantimicag.2007.05.023","article-title":"Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease","volume":"30","author":"JE Conte Jr","year":"2007","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/AAC.01533-06","article-title":"Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin","volume":"51","author":"T Gumbo","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"ref18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.diagmicrobio.2007.08.008","article-title":"Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections","volume":"60","author":"AL Kwa","year":"2008","journal-title":"Diagnostic microbiology and infectious disease"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/jac\/dkl403","article-title":"Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose","volume":"58","author":"KA Rodvold","year":"2006","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"ref20","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1128\/AAC.47.6.1853-1861.2003","article-title":"Pharmacokinetics and pharmacodynamics of cefepime in patients with various degrees of renal function","volume":"47","author":"VH Tam","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1128\/AAC.49.4.1337-1339.2005","article-title":"Comparison of the pharmacodynamics of meropenem in patients with ventilator-associated pneumonia following administration by 3-hour infusion or bolus injection","volume":"49","author":"S Jaruratanasirikul","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ijantimicag.2012.07.014","article-title":"Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia","volume":"40","author":"S Jaruratanasirikul","year":"2012","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"ref23","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1128\/AAC.01318-06","article-title":"Population pharmacokinetics and pharmacodynamics of continuous versus short-term infusion of imipenem-cilastatin in critically ill patients in a randomized, controlled trial","volume":"51","author":"SG Sakka","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"ref24","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1128\/AAC.00180-09","article-title":"Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model","volume":"53","author":"KL LaPlante","year":"2009","journal-title":"Antimicrobial agents and chemotherapy"},{"issue":"5","key":"ref25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijantimicag.2009.07.004","article-title":"Steady-state pharmacokinetics and pharmacodynamics of piperacillin\/tazobactam administered by prolonged infusion in hospitalised patients","volume":"34","author":"KM Shea","year":"2009","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"AP Magiorakos","year":"2012","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"5","key":"ref27","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"TC Horan","year":"2008","journal-title":"American journal of infection control"},{"issue":"4","key":"ref28","doi-asserted-by":"crossref","first-page":"c182","DOI":"10.1159\/000142926","article-title":"Definition and classification of acute kidney injury","volume":"109","author":"JA Kellum","year":"2008","journal-title":"Nephron Clinical practice"},{"issue":"12","key":"ref29","doi-asserted-by":"crossref","first-page":"e28177","DOI":"10.1371\/journal.pone.0028177","article-title":"Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B","volume":"6","author":"TP Lim","year":"2011","journal-title":"PloS one"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1469-0691.2011.03734.x","article-title":"Colistin: new lessons on an old antibiotic","volume":"18","author":"D Yahav","year":"2012","journal-title":"Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/00365548.2013.844350","article-title":"Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy","volume":"46","author":"R Crusio","year":"2014","journal-title":"Scandinavian journal of infectious diseases"},{"issue":"3","key":"ref32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"E Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"ref33","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jiac.2013.12.005","article-title":"Effectiveness of antibiotic combination therapy as evaluated by the Break-point Checkerboard Plate method for multidrug-resistant Pseudomonas aeruginosa in clinical use","volume":"20","author":"I Nakamura","year":"2014","journal-title":"Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0158740","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T09:02:09Z","timestamp":1692435729000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0158740"}},"subtitle":[],"editor":[{"given":"Sanjay Haresh","family":"Chotirmall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,21]]},"references-count":33,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0158740","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,21]]}}}